Our study suggests that SIRT1 deacetylase enhances NHEJ DNA damage repair efficiency in myeloid leukemia cells, and that targeting SIRT1 may provide a novel strategy for improving leukemia treatment and for overcoming DNA damage based chemotherapy resistance. Here, SIRT1 is linked to myeloid leukemia.